Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Piperno-Neumann

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
The Oncologist|January 31, 2012
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO)Isabelle Ray-Coquard, Antoine Italiano, Emmanuelle Bompas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2022
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCTGeert Spierenburg, Peter Grimison, Christine Chevreau, et al.
NPJ Precision Oncology|November 3, 2022
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiencyThomas Chabot, Fariba Nemati, Aurélie Herbette, et al.
Bulletin Du Cancer|January 18, 2021
Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ networkEmmanuelle Bompas, Valentine Martin, Fatima Meniai, et al.
Cancers|July 25, 2019
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020Manuel Rodrigues, Leanne de Koning, Sarah E Coupland, et al.
The Lancet. Oncology|February 15, 2015
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trialAxel Le Cesne, Jean-Yves Blay, Julien Domont, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcomaJoerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, et al.
International Journal of Cancer|February 24, 2006
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysisJacques-Olivier Bay, Isabelle Ray-Coquard, Jérôme Fayette, et al.
The Lancet. Oncology|March 25, 2018
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trialHans Gelderblom, Claire Cropet, Christine Chevreau, et al.
International Journal of Cancer|September 25, 2021
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma GroupElise Lavit, Mihaela Aldea, Sophie Piperno-Neumann, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
The Oncologist|January 31, 2012
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO)Isabelle Ray-Coquard, Antoine Italiano, Emmanuelle Bompas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2022
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCTGeert Spierenburg, Peter Grimison, Christine Chevreau, et al.
NPJ Precision Oncology|November 3, 2022
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiencyThomas Chabot, Fariba Nemati, Aurélie Herbette, et al.
Bulletin Du Cancer|January 18, 2021
Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ networkEmmanuelle Bompas, Valentine Martin, Fatima Meniai, et al.
Cancers|July 25, 2019
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020Manuel Rodrigues, Leanne de Koning, Sarah E Coupland, et al.
The Lancet. Oncology|February 15, 2015
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trialAxel Le Cesne, Jean-Yves Blay, Julien Domont, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcomaJoerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, et al.
International Journal of Cancer|February 24, 2006
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysisJacques-Olivier Bay, Isabelle Ray-Coquard, Jérôme Fayette, et al.
The Lancet. Oncology|March 25, 2018
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trialHans Gelderblom, Claire Cropet, Christine Chevreau, et al.
International Journal of Cancer|September 25, 2021
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma GroupElise Lavit, Mihaela Aldea, Sophie Piperno-Neumann, et al.
Pageof 15